Clinical Trials on Glabellar Frown Lines in Colombia
Total 33 results
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesCanada
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States, Canada
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
Merz North America, Inc.Completed
-
Merz North America, Inc.Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Germany, Canada
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Germany, Canada, United Kingdom
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Russian Federation, Germany, Canada, Belgium, United Kingdom
-
AllerganCompleted
-
AllerganCompleted
-
Merz Pharmaceuticals GmbHCompletedGlabellar LinesUnited States, Germany, Canada
-
AbbVieCompletedGlabellar LinesUnited States, Canada, Germany, Hungary, Poland
-
AllerganCompletedGlabellar Lines | Crow's Feet Lines | Facial RhytidesGermany, Canada, United States, France
-
AllerganCompletedGlabellar Lines | Crow's Feet Lines | Facial RhytidesGermany, Canada, United States, France
-
Revance Therapeutics, Inc.CompletedUpper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)United States, Canada
-
Advanced Cosmetic InterventionCompletedGlabellar FurrowingUnited States, Canada
-
AbbVieActive, not recruiting
-
AllerganCompletedCrow's Feet Lines | Lateral Canthus RhytidesBelgium, Canada, United States, United Kingdom
-
Galderma R&DCompletedLateral Canthal LinesUnited States, Canada
-
George Washington UniversityJohns Hopkins UniversityCompletedPatients With Peripheral Intravenous Access LinesUnited States
-
University of British ColumbiaCompletedCentral Line ComplicationCanada
-
AllerganCompletedGlabellar Rhytides | Forehead RhytidesUnited States, Canada, Ireland
-
AbbVieRecruiting
-
University of Missouri-ColumbiaTerminatedDiastasis Recti and Weakness of the Linea AlbaUnited States
-
National Institute of Diabetes and Digestive and...Vidacare CorporationWithdrawnCatheters, Indwelling | Central Venous Line | Intraosseous NeedleUnited States
-
Crown Laboratories, Inc.CompletedIchthyosis VulgarisUnited States
-
Fraser HealthSterileCare Inc.; Center for Health Evaluation & Outcome ServicesRecruitingCentral Venous Catheter Thrombosis | Catheter Infection | Catheter Complications | Catheter | Catheter Blockage | Catheter Dysfunction | Central Line-associated Bloodstream Infection (CLABSI) | Central Venous Catheter Related Bloodstream InfectionCanada
-
Novartis PharmaceuticalsCompleted3rd Line GISTFrance, United Kingdom, Belgium, Canada, Spain, Netherlands, Japan, United States
-
Timber Pharmaceuticals Inc.Active, not recruitingIchthyosisUnited States, Canada, Germany, France, Italy
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedFirst Line Non-Small Cell Lung CancerSpain, United States, Hungary, Israel, China, Korea, Republic of, Taiwan, Czechia, Russian Federation, Australia, Brazil, Lebanon, Serbia, Thailand, Canada, Slovakia, Ukraine, Bulgaria, Italy, Netherlands, New Zealand, Poland, Belgium, Turk... and more
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain